{"id":"https://openalex.org/W2000350300","doi":"https://doi.org/10.1111/j.1349-7006.2011.02041.x","title":"Phase I study of dasatinib (BMS\u2010354825) in Japanese patients with solid tumors","display_name":"Phase I study of dasatinib (BMS\u2010354825) in Japanese patients with solid tumors","alternate_titles":[],"publication_year":2011,"publication_date":"2011-09-01","ids":{"openalex":"https://openalex.org/W2000350300","doi":"https://doi.org/10.1111/j.1349-7006.2011.02041.x","mag":"2000350300","pmid":"https://pubmed.ncbi.nlm.nih.gov/21781226"},"language":"en","primary_location":{"id":"doi:10.1111/j.1349-7006.2011.02041.x","doi":"https://doi.org/10.1111/j.1349-7006.2011.02041.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2011.02041.x","pdf_url":null,"source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000350300"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018910129","display_name":"Shunji Takahashi","orcid":"https://orcid.org/0000-0002-5031-1953","observed_orcids":["https://orcid.org/0000-0002-5031-1953"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shunji Takahashi","raw_affiliation_strings":["The Cancer Institute Hospital of JFCR, Medical Oncology, Tokyo, Japan. stakahas@jfcr.or.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cancer Institute Hospital of JFCR, Medical Oncology, Tokyo, Japan. stakahas@jfcr.or.jp","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101955394","display_name":"Masaki Miyazaki","orcid":"https://orcid.org/0000-0001-8759-0645","observed_orcids":["https://orcid.org/0000-0001-8759-0645"]},"institutions":[{"id":"https://openalex.org/I4210094884","display_name":"Kindai University Hospital","ror":"https://ror.org/00qmnd673","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094884"]},{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masaki Miyazaki","raw_affiliation_strings":["Kinki University Faculty of Medicine, Medical Oncology, Osaka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinki University Faculty of Medicine, Medical Oncology, Osaka","institution_ids":["https://openalex.org/I4210094884","https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072724155","display_name":"Isamu Okamoto","orcid":"https://orcid.org/0000-0002-7587-6096","observed_orcids":["https://orcid.org/0000-0002-7587-6096"]},"institutions":[{"id":"https://openalex.org/I4210094884","display_name":"Kindai University Hospital","ror":"https://ror.org/00qmnd673","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094884"]},{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isamu Okamoto","raw_affiliation_strings":["Kinki University Faculty of Medicine, Medical Oncology, Osaka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinki University Faculty of Medicine, Medical Oncology, Osaka","institution_ids":["https://openalex.org/I4210094884","https://openalex.org/I916559398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101024720","display_name":"Yoshinori Ito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshinori Ito","raw_affiliation_strings":["The Cancer Institute Hospital of JFCR, Medical Oncology, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cancer Institute Hospital of JFCR, Medical Oncology, Tokyo","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055153528","display_name":"Kyoji Ueda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148404","display_name":"Bristol-Myers Squibb (Japan)","ror":"https://ror.org/04dbmrm19","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210148404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kyoji Ueda","raw_affiliation_strings":["Bristol\u2013Myers KK, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol\u2013Myers KK, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086840982","display_name":"Taku Seriu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148404","display_name":"Bristol-Myers Squibb (Japan)","ror":"https://ror.org/04dbmrm19","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4210148404"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Taku Seriu","raw_affiliation_strings":["Bristol\u2013Myers KK, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol\u2013Myers KK, Tokyo, Japan","institution_ids":["https://openalex.org/I4210148404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100648645","display_name":"Kazuhiko Nakagawa","orcid":"https://orcid.org/0000-0003-1284-9776","observed_orcids":["https://orcid.org/0000-0003-1284-9776"]},"institutions":[{"id":"https://openalex.org/I4210094884","display_name":"Kindai University Hospital","ror":"https://ror.org/00qmnd673","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094884"]},{"id":"https://openalex.org/I916559398","display_name":"Kindai University","ror":"https://ror.org/05kt9ap64","country_code":"JP","type":"education","lineage":["https://openalex.org/I916559398"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kazuhiko Nakagawa","raw_affiliation_strings":["Kinki University Faculty of Medicine, Medical Oncology, Osaka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinki University Faculty of Medicine, Medical Oncology, Osaka","institution_ids":["https://openalex.org/I4210094884","https://openalex.org/I916559398"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038191750","display_name":"Kiyohiko Hatake","orcid":"https://orcid.org/0000-0002-4153-4987","observed_orcids":["https://orcid.org/0000-0002-4153-4987"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kiyohiko Hatake","raw_affiliation_strings":["The Cancer Institute Hospital of JFCR, Medical Oncology, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cancer Institute Hospital of JFCR, Medical Oncology, Tokyo","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5018910129"],"corresponding_institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":null,"fwci":0.679,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.68082305,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"102","issue":"11","first_page":"2058","last_page":"2064"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.6474999785423279,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.6474999785423279,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.2062000036239624,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.01360000018030405,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":1.0},{"id":"https://openalex.org/keywords/src-family-kinases","display_name":"Src family kinases","score":0.8970000147819519},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8550000190734863},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.7099999785423279},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pleural-effusion","display_name":"pleural effusion","score":0.984000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9539999961853027},{"id":"https://openalex.org/keywords/bone-resorption-markers","display_name":"bone resorption markers","score":0.9150000214576721},{"id":"https://openalex.org/keywords/ntx","display_name":"NTX","score":0.7250000238418579},{"id":"https://openalex.org/keywords/tracp-5b","display_name":"TRACP-5b","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7670000195503235},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8874083757400513},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.8273487091064453},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6490311622619629},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6469824910163879},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5632477402687073},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.48267892003059387},{"id":"https://openalex.org/C2779634585","wikidata":"https://www.wikidata.org/wiki/Q1334541","display_name":"Pleural effusion","level":2,"score":0.47364604473114014},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4699150621891022},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4609883427619934},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.29563507437705994},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.2108197808265686},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000855","descriptor_name":"Anorexia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001862","descriptor_name":"Bone Resorption","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008274","descriptor_name":"Magnesium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D010010","descriptor_name":"Osteoclasts","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010996","descriptor_name":"Pleural Effusion","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019061","descriptor_name":"src-Family Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1349-7006.2011.02041.x","doi":"https://doi.org/10.1111/j.1349-7006.2011.02041.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2011.02041.x","pdf_url":null,"source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmid:21781226","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21781226","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G8679778108","display_name":"Elucidation of interaction between bone marrow micro-metastases in breast cancer patients","funder_award_id":"22501056","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1532635242","https://openalex.org/W1589166971","https://openalex.org/W1951471355","https://openalex.org/W1975948973","https://openalex.org/W1983225862","https://openalex.org/W1986905001","https://openalex.org/W1988786053","https://openalex.org/W1990915902","https://openalex.org/W2000170431","https://openalex.org/W2003973314","https://openalex.org/W2015423024","https://openalex.org/W2026991540","https://openalex.org/W2035060068","https://openalex.org/W2036118441","https://openalex.org/W2041924766","https://openalex.org/W2049802831","https://openalex.org/W2054177711","https://openalex.org/W2070307457","https://openalex.org/W2070568211","https://openalex.org/W2092343827","https://openalex.org/W2112505356","https://openalex.org/W2116153687","https://openalex.org/W2118263555","https://openalex.org/W2121881330","https://openalex.org/W2126579741","https://openalex.org/W2139248078","https://openalex.org/W2143060756","https://openalex.org/W2143974518","https://openalex.org/W2155490728","https://openalex.org/W2158196950","https://openalex.org/W2167383340","https://openalex.org/W2170309090","https://openalex.org/W2229800306","https://openalex.org/W2317628677","https://openalex.org/W2395867680","https://openalex.org/W2501548294"],"related_works":["https://openalex.org/W2143060756","https://openalex.org/W2987027416","https://openalex.org/W2111566545","https://openalex.org/W2230456973","https://openalex.org/W4234798212","https://openalex.org/W2601082076","https://openalex.org/W2027558943","https://openalex.org/W2090206737","https://openalex.org/W2167084563","https://openalex.org/W2599615113"],"abstract_inverted_index":{"Dasatinib":[0,51],"is":[1],"a":[2,189,205],"potent":[3],"oral":[4],"inhibitor":[5],"of":[6,111,193,207,236,244],"tyrosine":[7],"kinases":[8],"including":[9],"the":[10,69,143,151,177,185,233,253],"SRC":[11],"family":[12],"kinases,":[13],"which":[14],"are":[15],"activated":[16],"in":[17,21,43,68,131,162],"tumors,":[18],"and":[19,23,41,59,80,102,123,138,146,202,209,241],"implicated":[20],"invasion":[22],"bone":[24,194],"metastasis.":[25],"This":[26],"phase":[27],"I":[28],"dose-escalation":[29],"study":[30,231],"assessed":[31],"safety,":[32],"tolerability,":[33],"maximum":[34],"tolerated":[35],"dose":[36,186],"(MTD),":[37],"antitumor":[38],"activity,":[39],"pharmacokinetics":[40],"pharmacodynamics":[42],"Japanese":[44],"patients":[45,63,165,219],"with":[46,66,167],"refractory,":[47],"advanced":[48],"solid":[49],"tumors.":[50],"was":[52,160,173,238,249],"administered":[53,246],"once":[54,247],"daily":[55,248],"at":[56,142,150],"100,":[57],"150":[58,76,171,242],"200":[60,81,168],"mg/day.":[61],"Sixteen":[62],"were":[64,93,117,129,182,196,215],"treated":[65,166],"dasatinib":[67,237,245],"following":[70],"doses:":[71],"100":[72],"mg":[73,77,82,172,243],"(nine":[74],"patients),":[75],"(three":[78],"patients)":[79],"(four":[83],"patients).":[84],"The":[85,107,179],"most":[86,108],"frequent":[87,109],"adverse":[88],"events":[89],"(AE;":[90],"\u2265":[91,113],"50%)":[92],"anorexia,":[94],"fatigue,":[95],"pleural":[96,136,158],"effusion,":[97],"anemia,":[98,118],"constipation,":[99],"diarrhea,":[100],"vomiting":[101],"increased":[103,124],"aspartate":[104],"aminotransferase":[105],"(AST).":[106],"AE":[110],"grade":[112,134,147,156],"3":[114,148],"(\u2265":[115],"10%)":[116],"decreased":[119],"lymphocyte":[120],"count,":[121],"fatigue":[122],"blood":[125],"magnesium.":[126],"Dose-limiting":[127],"toxicities":[128],"observed":[130,161],"two":[132],"patients:":[133],"2":[135,157],"effusion":[137,159],"bronchial":[139],"wall":[140],"thickening":[141],"100-mg":[144],"level":[145],"dyspnea":[149],"200-mg":[152],"level.":[153],"In":[154,229],"addition,":[155],"all":[163],"four":[164],"mg.":[169],"Therefore,":[170],"determined":[174,250],"to":[175,251],"be":[176,252],"MTD.":[178,254],"pharmacokinetic":[180],"parameters":[181],"comparable":[183],"among":[184],"levels.":[187],"As":[188],"pharmacodynamic":[190],"study,":[191],"markers":[192],"metabolism":[195],"assessed.":[197],"Bone":[198],"resorption":[199],"markers,":[200],"NTx":[201],"TRACP-5b,":[203],"showed":[204],"decrease":[206],"46.3%":[208],"22.2%,":[210],"respectively.":[211],"No":[212],"objective":[213],"responses":[214],"observed,":[216],"but":[217],"three":[218],"had":[220],"stable":[221],"disease":[222],"that":[223],"lasted":[224],"for":[225],"over":[226],"6":[227],"months.":[228],"this":[230],"population,":[232],"safety":[234],"profile":[235],"generally":[239],"acceptable":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000350300","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
